Nesta página
MCRB Seres Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 5, 2026
$2,94
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$2,83mínima 52 sem
$29,98máxima 52 sem
Capitalização de Mercado (MRQ)
$29M
P/E (TTM)
-1.2
EPS (TTM)
$-2.45
Receita (TTM)
$2M
seus distintivos
Intervalo 52 Semanas
$3–$30
Classificação do Analista
BUY
Preço-Alvo
$17
P/E
-1.2
ROE
-66.6%
Margem de Lucro Líquido
-1192.9%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
MCRB Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$2.94
Capitalização de Mercado (MRQ)
$29M
P/E (TTM)
-1.2
EPS (TTM)
$-2.45
Receita (TTM)
$2M
ROE (TTM)
-66.6%
Intervalo 52 Semanas
$3–$30
MCRB Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 22 de Abril de 2025 | 1-for-20 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$789.0K2016-12-31 → 2025-12-31
EPS$0.642020-12-31 → 2025-12-31
Fluxo de caixa livre$865.0K2016-12-31 → 2025-12-31
Margem líquida-1192.9%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | MCRB | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -1.2média 5A ≈-64.5 | ≈-64.5 | · | · | |
| P/S (TTM) | 15.3média 5A ≈751.1 | ≈751.1 | 79.9 | Subvalorizado | |
| P/B (MRQ) | 0.8média 5A ≈308.9 | ≈308.9 | 2.2 | Sobreavaliado | |
| Preço / FCF (TTM) | -0.6média 5A ≈-1052.6 | ≈-1052.6 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -0.6média 5A ≈460.7 | ≈460.7 | · | · | |
| Price / Tangible Book (Preço / Valor Patrimonial Tangível) | 0.6média 5A ≈407.2 | ≈407.2 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | MCRB | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | -4462.8%média 5A ≈-3874.5% | ≈-3874.5% | -5293.3% | Primeira linha | |
| Margem EBITDA (TTM) | -4279.6%média 5A ≈-3718.1% | ≈-3718.1% | -5247.7% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | -1192.9%média 5A ≈-730.7% | ≈-730.7% | -4906.2% | Primeira linha | |
| ROA (TTM) | -18.3%média 5A ≈-23.6% | ≈-23.6% | -40.8% | Primeira linha | |
| ROE (TTM) | -66.6%média 5A ≈-57.3% | ≈-57.3% | -107.8% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | MCRB | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 2.1média 5A ≈2.2 | ≈2.2 | 2.0 | Em linha | |
| Quick Ratio (Índice de Liquidez Seca) | 2.4média 5A ≈2.0 | ≈2.0 | 0.8 | Em linha |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | MCRB | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (CAGR Receita 3A) | -52.0% | · | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -52.7% | · | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | 4088.2% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | MCRB | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.0média 5A ≈0.2 | ≈0.2 | 0.0 | Em linha | |
| Receivables Turnover (Giro de Contas a Receber) | 10.1 | · | 6.6 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$12.0K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-49.6%
Próximo relatório
Nov 03, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 4, 2026 | $1.07 | $-2.23 | 148.0% |
| 31 de Março de 2026 | $-2.08 | $-1.92 | -8.5% | |
| 31 de Dezembro de 2025 | $-1.78 | $-2.15 | 17.3% | |
| 30 de Setembro de 2025 | $0.94 | $1.31 | -28.0% | |
| 30 de Junho de 2025 | $-2.27 | $-2.54 | 10.7% | |
| 31 de Março de 2025 | $-2.96 | $-0.55 | -437.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| R&D Expense | $49M | $65M | $118M | $110M | $142M | $91M | $80M | $96M | $89M | $82M | $38M | |
| SG&A Expense | $39M | $53M | $78M | $70M | $69M | $31M | $25M | $33M | $34M | $33M | $17M | |
| Operating Expenses | $95M | $121M | $195M | $180M | $209M | $121M | $106M | $129M | $123M | $115M | $55M | |
| Operating Income | $-94M | $-121M | $-195M | $-180M | $-64M | $-88M | $-72M | $-100M | $-91M | $-93M | $-55M | |
| Interest Income | $2M | $4M | $7M | $3M | $3M | $946.0K | $1M | $1M | $2M | · | · | |
| Other Non-op | $17M | $-14M | $134.0K | $-705.0K | $-1M | $981.0K | $1M | $1M | $2M | $1M | $76.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| EPS (Basic) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| EPS (Diluted) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| Shares (Basic) | 8,858,975 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| Shares (Diluted) | 8,869,742 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| EBITDA | $-90M | $-116M | $-102M | $-240M | $-59M | $-82M | $-64M | $-92M | $-84M | $-89M | $-54M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $31M | $128M | $163M | $180M | $116M | $65M | $86M | $36M | $55M | $74M | |
| Short-term Investments | · | · | $0 | $18M | $111M | $138M | $30M | · | $114M | $139M | $131M | |
| Receivables | $157.0K | $0 | · | · | · | $9M | $2M | · | · | · | · | |
| Inventory | · | · | $30M | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $6M | $8M | $13M | $13M | $6M | $4M | $7M | $5M | $5M | $3M | |
| Current Assets | $49M | $39M | $175M | $195M | $304M | $269M | $100M | $93M | $155M | $198M | $208M | |
| PP&E (Net) | $8M | $12M | $18M | $23M | $18M | $14M | $19M | $26M | $33M | $36M | $8M | |
| PP&E (Gross) | $64M | $65M | $67M | $68M | $58M | $48M | $47M | $47M | $45M | $41M | $9M | |
| Accum. Depreciation | $57M | $53M | $49M | $45M | $40M | $34M | $28M | $20M | $12M | $5M | $1M | |
| Other Non-current Assets | $31.0K | $31.0K | $2M | $10M | $5M | · | · | · | · | · | · | |
| Total Assets | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Accounts Payable | $2M | $4M | $4M | $17M | $14M | $4M | $5M | $6M | $7M | $8M | $5M | |
| Short-term Debt | · | · | $0 | $456.0K | $0 | $454.0K | · | · | · | · | · | |
| Current Liabilities | $19M | $41M | $99M | $86M | $82M | $46M | $46M | $42M | $32M | $30M | $11M | |
| Capital Leases | $73M | $83M | $92M | $108M | $18M | $11M | $16M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $11M | $1M | $502.0K | $644.0K | $1M | · | · | |
| Total Liabilities | $94M | $126M | $403M | $338M | $223M | $168M | $181M | $169M | $129M | $140M | $12M | |
| Long-term Debt | · | · | $110M | $50M | $24M | $25M | $25M | · | · | · | · | |
| Total Debt | · | · | $0 | $456.0K | · | $454.0K | · | · | · | · | · | |
| Common Stock | $10.0K | $9.0K | $135.0K | $125.0K | $92.0K | $91.0K | $70.0K | $41.0K | $40.0K | $40.0K | $39.0K | |
| Retained Earnings | $-972M | $-978M | $-978M | $-865M | $-614M | $-549M | $-460M | $-389M | $-264M | $-174M | $-83M | |
| AOCI | · | $0 | $0 | $-12.0K | $-60.0K | $-47.0K | · | · | $-146.0K | $-149.0K | $30.0K | |
| Stockholders' Equity | $44M | $14M | $-45M | $11M | $132M | $175M | $-48M | $-48M | $61M | $133M | $205M | |
| Liabilities + Equity | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Shares Outstanding | 9,556,466 | 8,650,227 | 6,752,073 | 6,261,400 | 91,889,418 | 91,459,239 | 70,143,252 | 40,936,735 | 40,571,015 | 40,355,753 | 39,082,017 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $5M | $6M | $7M | $6M | $7M | $8M | $8M | $7M | $4M | $728.0K | |
| Stock-based Comp | $11M | $21M | $34M | $25M | $20M | $9M | $8M | $17M | $17M | $17M | $10M | |
| Restructuring | $1M | · | $6M | · | $0 | $0 | $1M | $0 | $0 | · | · | |
| Other Non-cash | $-20M | $-175M | $-44M | $-11M | $46M | $-20M | $-22M | $12M | $-11M | $114M | $4M | |
| Operating Cash Flow | $1M | $-149M | $-117M | $-229M | $7M | $-94M | $-77M | $-63M | $-76M | $44M | $-41M | |
| CapEx | $252.0K | $380.0K | $8M | $10M | $10M | $591.0K | $1M | $2M | $5M | $21M | $4M | |
| Investing Cash Flow | $-42.0K | $142M | $11M | $82M | $64M | $-159M | $-31M | $112M | $56M | $-66M | · | |
| Debt Issued | · | · | · | $28M | $0 | $0 | $25M | · | · | · | · | |
| Net Debt Issued | · | · | · | $28M | · | · | $25M | · | · | · | · | |
| Stock Issued | · | $0 | $0 | $97M | $0 | $244M | $61M | · | · | · | $143M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Net Stock Activity | · | $0 | $0 | $97M | · | $244M | $61M | · | $-33.0K | · | $143M | |
| Financing Cash Flow | $14M | $-90M | $72M | $130M | $1M | $303M | $86M | $268.0K | $83.0K | $2M | · | |
| Net Change in Cash | · | · | · | · | · | $51M | $-21M | $50M | $-20M | $-20M | $-40M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $865.0K | $-149M | $-125M | $-239M | $-3M | $-94M | $-78M | $-65M | $-80M | $22M | $-45M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11910.1% | · | -85.5% | -3458.1% | -44.5% | -265.3% | -208.3% | -354.8% | -284.7% | -426.5% | · | |
| Net Margin | 721.9% | · | -90.0% | -3509.5% | -45.2% | -268.3% | -203.7% | -350.0% | -278.4% | -420.7% | · | |
| EBITDA Margin | -11386.3% | · | -80.5% | -3365.1% | -40.4% | -245.5% | -186.3% | -327.0% | -262.1% | -407.2% | · | |
| ROA | 4.1% | 0.05% | -32.1% | -71.1% | -18.8% | -37.5% | -55.6% | -63.8% | -38.7% | -37.4% | -32.8% | |
| ROE | 14.8% | 0.72% | 379.2% | -638.4% | -42.7% | -49.1% | 174.5% | 251.7% | -92.5% | -54.2% | -61.3% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 | 5.8 | 2.2 | 2.2 | 4.9 | 6.5 | 19.0 | |
| Quick Ratio | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 | 5.7 | 1.5 | 2.0 | 4.7 | 6.3 | 18.8 | |
| Debt / Equity | · | · | 0.0 | 0.0 | · | 0.0 | · | · | · | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.4 | 0.0 | 0.4 | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | |
| Receivables Turnover | 10.1 | · | · | · | · | 5.9 | 38.7 | · | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.63 | $0.08 | $-0.33 | $0.09 | $1.43 | $1.91 | $-0.69 | $-1.17 | $1.50 | $3.29 | $5.26 | |
| Revenue / Share | $0.09 | · | $0.99 | $0.07 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.13 | $-0.96 | $-0.92 | $-2.12 | · | · | · | · | · | · | · | |
| Cash / Share | $4.79 | $0.18 | $0.95 | $1.30 | $1.96 | $1.27 | $0.93 | $2.10 | $0.89 | $1.35 | $1.89 | |
| EPS (TTM) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -95.1% | 336.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -52.0% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -52.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4088.2% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| Net Income TTM | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| Market Cap | $142M | $2.88B | $3.78B | $14.02B | $15.31B | $44.82B | $4.84B | $3.70B | $8.23B | $7.99B | $27.43B | |
| Enterprise Value | · | · | $3.65B | $13.84B | · | $44.56B | · | · | · | · | · | |
| P/E | 23.2 | · | -1.6 | -48.5 | -231.4 | -437.5 | · | · | · | · | · | |
| P/S | 180.2 | · | · | 1967.6 | 105.6 | 1349.2 | 140.3 | 130.9 | 256.3 | 367.1 | · | |
| P/B | 3.2 | 208.6 | -84.3 | 1300.6 | 116.4 | 256.5 | -100.2 | -77.0 | 135.6 | 60.2 | 133.5 | |
| P / Tangible Book | 3.2 | 208.6 | · | 1300.6 | 116.4 | 256.5 | · | · | · | · | · | |
| P / Cash Flow | 127.3 | -19.3 | -32.2 | -61.3 | 2289.0 | -478.7 | -63.2 | -58.9 | -108.9 | 181.9 | -671.5 | |
| P / FCF | 164.4 | -19.3 | -30.2 | -58.8 | -5319.2 | -475.7 | -62.4 | -57.1 | -102.6 | 356.3 | -606.7 | |
| EV / EBITDA | · | · | -35.9 | -57.7 | · | -546.4 | · | · | · | · | · | |
| EV / FCF | · | · | -29.1 | -58.0 | · | -473.1 | · | · | · | · | · | |
| EV / Revenue | · | · | · | 1942.2 | · | 1341.6 | · | · | · | · | · | |
| Earnings Yield | 4.3% | 0.00% | -63.5% | -2.1% | -0.43% | -0.23% | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $736.0K | $358.0K | $438.0K | $351.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-126M | $310.0K | $126M | $-522.0K | · | $3M | |
| R&D Expense | $9M | $13M | $12M | $13M | $13M | $12M | $13M | $16M | $16M | $19M | $2M | $25M | $47M | $44M | $-17M | $43M | |
| SG&A Expense | $7M | $8M | $8M | $9M | $10M | $12M | $12M | $13M | $13M | $15M | $8M | $19M | $28M | $22M | $13M | $18M | |
| Operating Expenses | $22M | $21M | $20M | $23M | $25M | $27M | $29M | $29M | $29M | $34M | $4M | $45M | $77M | $70M | $-4M | $63M | |
| Operating Income | $-21M | $-21M | $-19M | $-22M | $-25M | $-27M | $-29M | $-29M | $-29M | $-34M | $-129M | $-45M | $50M | $-71M | $-2M | $-59M | |
| Interest Income | $181.0K | $325.0K | $445.0K | $618.0K | $546.0K | $618.0K | $437.0K | $652.0K | $1M | $2M | $2M | $3M | $2M | $1M | $1M | $865.0K | |
| Other Non-op | $673.0K | $669.0K | $2M | $3M | $4M | $7M | $6M | $-23M | $1M | $505.0K | $336.0K | $999.0K | $-2M | $310.0K | $-23.0K | $-33.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $5M | $-20M | $-15M | $8M | $-20M | $33M | $-16M | $89M | $-33M | $-40M | $-41M | $-48M | $47M | $-71M | $-69M | $-60M | |
| EPS (Basic) | $0.47 | $-2.08 | $-1.79 | $0.94 | $-2.27 | $3.76 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| EPS (Diluted) | $0.47 | $-2.08 | $-1.78 | $0.94 | $-2.27 | $3.75 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| Shares (Basic) | 9,706,193 | 9,582,533 | · | 8,758,692 | 8,743,733 | 8,703,221 | · | 7,632,242 | 7,575,620 | 7,305,026 | · | 128,289,871 | 127,713,486 | 125,862,975 | · | 122,527,275 | |
| Shares (Diluted) | 9,747,138 | 9,582,533 | · | 8,771,519 | 8,743,733 | 8,714,701 | · | 7,632,242 | 7,575,620 | 7,305,026 | · | 128,289,871 | 129,844,931 | 125,862,975 | · | 122,527,275 | |
| EBITDA | $-21M | $-20M | · | $-21M | $-24M | $-26M | · | $-28M | $-30M | $-38M | · | $-46M | $51M | $-69M | · | $-57M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $30M | $46M | $48M | $45M | $59M | $31M | $67M | $71M | $111M | · | $170M | $230M | $95M | · | $205M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $28M | |
| Receivables | $274.0K | $233.0K | $157.0K | $351.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | $53M | $42M | · | $19M | $5M | · | · | · | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $4M | $6M | $6M | $6M | $5M | · | $9M | $9M | $10M | · | $15M | |
| Current Assets | $42M | $32M | $49M | $52M | $49M | $66M | $39M | $73M | $149M | $165M | · | $214M | $251M | $116M | · | $248M | |
| PP&E (Net) | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $18M | $19M | · | $24M | $24M | $24M | · | $19M | |
| PP&E (Gross) | $61M | $64M | $64M | $65M | $65M | $65M | $65M | $65M | $72M | $72M | · | $73M | $72M | $71M | · | $65M | |
| Accum. Depreciation | $55M | $57M | $57M | $56M | $55M | $54M | $53M | $52M | $54M | $52M | · | $50M | $48M | $46M | · | $45M | |
| Other Non-current Assets | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $465.0K | $42M | $41M | · | $12M | $11M | $11M | · | $12M | |
| Total Assets | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Accounts Payable | $1M | $2M | $2M | $2M | $2M | $2M | $4M | $8M | $5M | $5M | · | $9M | $13M | $12M | · | $10M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Current Liabilities | $20M | $19M | $19M | $22M | $31M | $31M | $41M | $65M | $108M | $98M | · | $79M | $78M | $64M | · | $82M | |
| Capital Leases | $45M | $70M | $73M | $75M | $78M | $80M | $83M | $85M | $101M | $103M | · | $105M | $107M | $107M | · | $18M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $961.0K | |
| Total Liabilities | $67M | $91M | $94M | $100M | $111M | $114M | $126M | $155M | $409M | $401M | · | $383M | $384M | $318M | · | $244M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $110M | $110M | · | $110M | $110M | $50M | · | $50M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $170.0K | $152.0K | $151.0K | · | $129.0K | $128.0K | $127.0K | · | $124.0K | |
| Retained Earnings | $-988M | $-992M | $-972M | $-957M | $-965M | $-945M | $-978M | $-962M | $-1.05B | $-1.02B | · | $-937M | $-889M | $-936M | · | $-796M | |
| AOCI | · | · | · | $0 | $0 | · | · | $0 | $0 | $0 | · | $0 | $-1.0K | $2.0K | · | $-118.0K | |
| Stockholders' Equity | $35M | $26M | $44M | $44M | $33M | $50M | $14M | $24M | $-87M | $-60M | $-45M | $-15M | $23M | $-48M | $11M | $68M | |
| Liabilities + Equity | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Shares Outstanding | 9,827,569 | 9,592,326 | 9,556,446 | 8,764,664 | 8,754,482 | 8,732,187 | 8,650,227 | 170,200,253 | 151,633,922 | 151,442,034 | 6,752,073 | 128,630,689 | 128,037,679 | 126,592,604 | 125,222,273 | 124,410,917 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $670.0K | $781.0K | $954.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| Stock-based Comp | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $5M | $9M | $13M | $7M | $7M | $6M | |
| Restructuring | $0 | $914.0K | $0 | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $1M | · | · | · | $-10M | · | · | · | $-3M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-22M | $-16M | $-15M | $2M | $-13M | $27M | $-39M | $-35M | $-40M | $-35M | $-47M | $-59M | $66M | $-77M | $-53M | $-60M | |
| CapEx | $0 | $0 | $29.0K | $8.0K | $181.0K | $34.0K | $90.0K | $129.0K | $99.0K | $62.0K | $877.0K | $2M | $1M | $4M | $3M | $1M | |
| Investing Cash Flow | $14.0K | $0 | $181.0K | $-8.0K | $-181.0K | $-34.0K | $-90.0K | $141M | $1M | $-62.0K | $-877.0K | $-2M | $11M | $3M | $6M | $40M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | |
| Financing Cash Flow | $2M | $428.0K | $13M | $61.0K | $0 | $1M | $2M | $-111M | $0 | $19M | $6M | $1M | $58M | $6M | $5M | $98M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $135M | $-68M | · | $79M | |
| Free Cash Flow | · | $-16M | · | · | · | $27M | · | · | · | $-35M | · | · | · | $-81M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2890.3% | -5839.9% | · | -6403.7% | · | · | · | · | · | · | · | -15294.5% | 39.2% | 13518.8% | · | -1716.2% | |
| Net Margin | 622.4% | -5562.3% | · | 2337.3% | · | · | · | · | · | · | · | -15436.8% | 36.8% | 13634.9% | · | -1742.2% | |
| EBITDA Margin | -2799.3% | -5621.8% | · | -6106.3% | · | · | · | · | · | · | · | -14751.3% | 40.4% | 13250.6% | · | -1665.5% | |
| ROA | 3.7% | -14.1% | · | 5.1% | -8.5% | 12.9% | · | 32.5% | -9.0% | -13.1% | · | -14.1% | 13.7% | -24.1% | · | -17.0% | |
| ROE | 13.6% | -51.7% | · | 24.3% | 73.4% | -704.9% | · | 2018.6% | 102.0% | 74.6% | · | -182.4% | 203.8% | -430.2% | · | -49.3% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.6 | · | 2.3 | 1.6 | 2.1 | · | 1.1 | 1.4 | 1.7 | · | 2.7 | 3.2 | 1.8 | · | 3.0 | |
| Quick Ratio | 0.8 | 1.6 | · | 2.1 | 1.5 | 1.9 | · | 1.0 | 0.7 | 1.1 | · | 2.1 | 2.9 | 1.7 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.4 | -0.0 | · | 0.0 | |
| Receivables Turnover | 1.0 | 0.3 | · | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.51 | $2.76 | · | $4.99 | $3.76 | $5.78 | · | $0.14 | $-0.57 | $-0.39 | · | $-0.12 | $0.18 | $-0.38 | · | $0.54 | |
| Revenue / Share | $0.08 | $0.04 | · | $0.04 | · | · | · | · | $0.00 | $0.00 | · | $0.00 | $0.97 | $-0.00 | · | $0.03 | |
| Cash Flow / Share | · | $-1.71 | · | · | · | $3.09 | · | · | · | $-0.24 | · | · | · | $-0.61 | · | · | |
| Cash / Share | $1.59 | $3.11 | · | $5.44 | $5.18 | $6.74 | · | $0.39 | $0.47 | $0.73 | · | $1.32 | $1.79 | $0.75 | · | $1.65 | |
| EPS (TTM) | $-2.45 | $-5.19 | · | $0.62 | $11.31 | $9.24 | · | $-15.39 | $-27.39 | $-22.69 | · | $-1.09 | $-1.21 | $-2.27 | · | $-2.35 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $1M | · | $351.0K | $0 | $0 | · | $-126M | $-126M | $522.0K | · | · | · | · | · | $13M | |
| Net Income TTM | $-22M | $-47M | · | $5M | $86M | $73M | · | $-25M | $-162M | $-83M | · | $-141M | $-153M | $-265M | · | $-231M | |
| Market Cap | $78M | $85M | · | $169M | $97M | $122M | · | $3.22B | $2.20B | $2.34B | · | $6.12B | $12.27B | $14.36B | · | $15.97B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.95B | $12.04B | $14.25B | · | · | |
| P/E | -3.2 | -1.7 | · | 31.0 | 1.0 | 1.5 | · | -1.2 | -0.5 | -0.7 | · | -43.7 | -79.2 | -50.0 | · | -54.6 | |
| P/S | 41.2 | 74.2 | · | 480.4 | · | · | · | -25.5 | -17.4 | 4491.0 | · | · | · | · | · | 1194.4 | |
| P/B | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | -25.2 | -39.2 | · | -404.9 | 542.4 | -299.9 | · | 236.4 | |
| P / Tangible Book | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | · | · | · | · | 542.4 | · | · | 236.4 | |
| P / Cash Flow | · | -5.2 | · | · | · | 4.5 | · | · | · | -66.5 | · | · | · | -187.4 | · | · | |
| Earnings Yield | -31.1% | -58.5% | · | 3.2% | 101.8% | 66.0% | · | -81.3% | -189.2% | -146.6% | · | -2.3% | -1.3% | -2.0% | · | -1.8% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $789.0K | $0 | $0 | $7M | $145M |
| Margem Operacional % | -11910.1% | · | -85.5% | -3458.1% | -44.5% |
| Lucro líquido | $6M | $136.0K | $-114M | $-250M | $-66M |
| EPS Diluído | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | · | · | 0.0 | 0.0 | · |
| Índice de liquidez corrente | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 |
| Índice de Liquidez Seca | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $865.0K | $-149M | $-125M | $-239M | $-3M |
Investidores institucionais (13F) 41 declarantes · $18.2M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
41
Valor detido
$18.2M
Novas posições
8
Posições encerradas
5
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 8 (+2 vs trimestre anterior) | 5 (-2 vs trimestre anterior) | 7 (-3 vs trimestre anterior) | 14 (+3 vs trimestre anterior) | -84K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4.824.304 | 324.214 | 26,48% | Ações |
| Flagship Pioneering, LLC | $3.334.654 | 422.643 | 18,30% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.270.553 | 287.776 | 12,46% | Ações |
| MARSHALL WACE, LLP | $1.359.016 | 172.245 | 7,46% | Ações |
| Vontobel Holding Ltd. | $970.273 | 122.975 | 5,32% | Ações |
| BlackRock, Inc. | $875.790 | 111.000 | 4,81% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $631.301 | 79.974 | 3,46% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $503.382 | 63.800 | 2,76% | Opção de venda |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $460.208 | 58.328 | 2,53% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $384.125 | 48.685 | 2,11% | Ações |
| CITADEL ADVISORS LLC | $343.215 | 43.500 | 1,88% | Opção de venda |
| HAP Trading, LLC | $334.750 | 125.000 | 1,84% | Opção de compra |
| STATE STREET CORP | $267.479 | 33.901 | 1,47% | Ações |
| Lion Point Capital, LP | $249.087 | 31.570 | 1,37% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $244.977 | 31.049 | 1,34% | Ações |
| AMERICAN CENTURY COMPANIES INC | $223.390 | 28.313 | 1,23% | Ações |
| XTX Topco Ltd | $163.575 | 20.732 | 0,90% | Ações |
| GOLDMAN SACHS GROUP INC | $120.157 | 15.229 | 0,66% | Ações |
| NORTHERN TRUST CORP | $116.496 | 14.765 | 0,64% | Ações |
| Invesco Ltd. | $102.365 | 12.974 | 0,56% | Ações |
| MORGAN STANLEY | $95.769 | 12.138 | 0,53% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87.579 | 11.100 | 0,48% | Opção de compra |
| CITADEL ADVISORS LLC | $82.877 | 10.504 | 0,45% | Ações |
| SIMPLEX TRADING, LLC | $36.278 | 4.598 | 0,20% | Ações |
| SBI Securities Co., Ltd. | $32.996 | 4.182 | 0,18% | Ações |
| GROUP ONE TRADING LLC | $29.303 | 3.714 | 0,16% | Ações |
| JPMORGAN CHASE & CO | $28.325 | 3.636 | 0,16% | Ações |
| Vanguard Global Advisers, LLC | $15.583 | 1.975 | 0,09% | Ações |
| FMR LLC | $12.056 | 1.528 | 0,07% | Ações |
| Rachor Investment Advisory Services, LLC | $11.654 | 1.477 | 0,06% | Ações |
| UBS Group AG | $3.818 | 484 | 0,02% | Ações |
| Tower Research Capital LLC (TRC) | $2.493 | 316 | 0,01% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $1.665 | 211 | 0,01% | Ações |
| BARCLAYS PLC | $1.318 | 167 | 0,01% | Ações |
| Continuum Advisory, LLC | $371 | 47 | 0,00% | Ações |
| Sandy Spring Bank | $242 | 345 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $79 | 10 | 0,00% | Ações |
| OSAIC HOLDINGS, INC. | $63 | 8 | 0,00% | Ações |
| Larson Financial Group LLC | $39 | 5 | 0,00% | Ações |
| WHITTIER TRUST CO OF NEVADA INC | $8 | 1 | 0,00% | Ações |
| ROYAL BANK OF CANADA | $0 | 11 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 4 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Nestlé S.A., Société des Produits Nestlé S.A. | 2 de Outubro de 2024 | · | Declaração inicial | · | SEC |
| Nestle Health Science US Holdings, Inc., NIMCO US, Inc., Nestlé S.A., Nestlé US Holdco, Inc., Société des Produits Nestlé S.A. ×2 declarações | 22 de Julho de 2022 | · | Declaração inicial | · | SEC |
| Flagship VentureLabs IV, LLC (2), Flagship Ventures Fund IV, L.P. (2), Flagship Ventures Fund IV-Rx, L.P. (2), Flagship Ventures Fund IV General Partner LLC (2), Nutritional Health LTP Fund, L.P. (2), Nutritional Health LTP Fund General Partner LLC (2), Flagship Pioneering Fund VI, L.P. (2), Flagship Pioneering Fund VI General Partner LLC (2), Flagship Pioneering Fund VII, L.P. (2), Flagship Pioneering Fund VII General Partner LLC (2), Flagship Pioneering, Inc. (2), Noubar B. Afeyan, Ph.D. (2) ×3 declarações | 7 de Julho de 2022 | · | Declaração inicial | · | SEC |
| Nestle Health Science US Holdings, Inc. (1), NIMCO US, Inc. (1), Nestlé S.A., Nestlé US Holdco, Inc. (1), Société des Produits Nestlé S.A. | 19 de Agosto de 2020 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 32 insiders · 16 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Richard N Kender | Interim Chief Executive Officer | 8 de Julho de 2026 A | 63.492 | 0 | 0 | $0 |
| Marella Thorell | EVP and Chief Financial Officer | 8 de Julho de 2026 A | · | 0 | 0 | $0 |
| David Arkowitz | Chief Financial Officer | 15 de Fevereiro de 2024 M | 182.442 | 0 | 0 | $0 |
| Matthew R. Henn | President and Chief Scientific Officer | 15 de Agosto de 2026 M | 7.995 | 0 | 4 | $-23.449 |
| Kelly Brady | EVP, Chief Operating Officer | 15 de Agosto de 2026 M | 8.679 | 0 | 2 | $-735 |
| Thomas Desrosier | EVP and Chief Legal Officer | 15 de Agosto de 2026 M | 8.117 | 0 | 4 | $-2.944 |
| Teresa L. Young | EVP, Chief Commercial & Strategy Officer | 15 de Fevereiro de 2026 M | 8.557 | 0 | 2 | $-18.662 |
| Lisa Von Moltke | Executive Vice President and Chief Medical Officer | 15 de Fevereiro de 2025 M | 39.875 | 0 | 0 | $0 |
| David S. Ege | Executive Vice President and Chief Technology Officer | 15 de Agosto de 2024 M | 77.575 | 0 | 0 | $0 |
| Paula Cloghessy | Executive Vice President, Chief People Officer | 27 de Outubro de 2023 M | 45.684 | 0 | 0 | $0 |
| Marcus Chapman | SVP, Principal Financial and Accounting Officer | 4 de Fevereiro de 2021 A | 8.600 | 0 | 0 | $0 |
| John G. Aunins | Chief Technology Officer & EVP | 29 de Janeiro de 2020 A | 105.250 | 0 | 0 | $0 |
| David N Cook | Chief Scientific Officer and EVP of R&D | 26 de Janeiro de 2019 M | 147.435 | 0 | 0 | $0 |
| Kevin Horgan | Chief Medical Officer and EVP | 25 de Janeiro de 2019 A | · | 0 | 0 | $0 |
| Michele Trucksis | Chief Medical Officer and EVP | 30 de Janeiro de 2018 A | 4.893 | 0 | 0 | $0 |
| Wael Hashad | EVP & Chief Commercial Officer | 26 de Janeiro de 2017 A | · | 0 | 0 | $0 |
| Eric D. Shaff | Conselheiro | 15 de Agosto de 2026 M | 12.499 | 0 | 4 | $-9.095 |
| Stephen Berenson | Conselheiro | 8 de Julho de 2026 A | 3.589 | 0 | 0 | $0 |
| Robert L. Rosiello | Conselheiro | 8 de Julho de 2026 A | · | 0 | 0 | $0 |
| Kurt Graves | Conselheiro | 8 de Julho de 2026 A | · | 0 | 0 | $0 |
| Claire Fraser | Conselheiro | 8 de Julho de 2026 A | · | 0 | 0 | $0 |
| Dennis A Ausiello | Conselheiro | 8 de Julho de 2026 A | · | 0 | 0 | $0 |
| Willard H Dere | Conselheiro | 8 de Julho de 2026 A | 31.746 | 0 | 0 | $0 |
| Paul Biondi | Conselheiro | 10 de Abril de 2025 A | 47.619 | 0 | 0 | $0 |
| Hans-Juergen Woerle | Conselheiro | 4 de Fevereiro de 2025 A | · | 0 | 0 | $0 |
| Gregory Behar | Conselheiro | 22 de Junho de 2023 A | · | 0 | 0 | $0 |
| Meryl Zausner | Conselheiro | 5 de Julho de 2022 A | 31.746 | 0 | 0 | $0 |
| AFEYAN NOUBAR | Conselheiro | 18 de Junho de 2019 P | 4.444.444 | 0 | 0 | $0 |
| Lorence H. Kim | Conselheiro | 13 de Junho de 2019 A | · | 0 | 0 | $0 |
| Roger Pomerantz | Conselheiro | 13 de Junho de 2019 A | 213.976 | 0 | 0 | $0 |
| Peter Barton Hutt | Conselheiro | 15 de Junho de 2016 A | · | 0 | 0 | $0 |
| Werner Cautreels | Conselheiro | 25 de Junho de 2015 A | · | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 4 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 25.222 SH | 11 de Setembro de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 12.603 SH | 2 de Outubro de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 75.849 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 206.170 SH | 19 de Agosto de 2026 | Diário |
MCRB Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 8 analistas
COMPRA
Alvo mediano
$17.00
+478,2%
2 25,0%
Compra forte
5 62,5%
Compra
1 12,5%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
2 analistas · 2026-10-03Alvo médio $17.00 +478,2%
← Abaixo de todos os alvos
Preço atual $2.94
Mín$12.00
Média$17.00
Máx$22.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MCRB | $142M | 23.2 | · | 721.9% | 14.8% | · |
| BYSI | · | · | · | · | 3.1% | · |
| ABVC | $53M | -5.5 | 234.3% | · | -128.2% | · |
| QNCX | $187M | -2.0 | · | · | 700.5% | · |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | · |
| RNAZ | · | -0.1 | · | · | · | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| GRDX | $20M | -1.1 | · | -17634.4% | -68.6% | -1813.6% |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 5, 2026